# EGATEN
> **NDA208711** · New Drug Application · Sponsor: NOVARTIS · Approved 2019-02-13
## Drug
- **FDA Application Number:** NDA208711
- **Application type:** New Drug Application
- **Brand name:** EGATEN
- **Generic name:** TRICLABENDAZOLE
- **Active ingredients:** TRICLABENDAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2019-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208711)
---
*AI Analytics · CC0 1.0*